Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (5)

Trial Status

Recruiting3
Active Not Recruiting2
Not Yet Recruiting1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07622446Not ApplicableActive Not RecruitingPrimary

Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).

NCT06274411Not ApplicableRecruiting

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

NCT07380217Not ApplicableRecruitingPrimary

Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures

NCT07010965Not ApplicableActive Not RecruitingPrimary

SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI

NCT06754839Not ApplicableNot Yet Recruiting

Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI)

NCT05466552RecruitingPrimary

The PROTECT-EU Study

Showing all 6 trials

Research Network

Activity Timeline